The Dundee Advanced Interventions Service is a specialist service providing: intensive treatment for obsessive-compulsive disorder (OCD); specialist assessment and treatment for depression and OCD; and neurosurgical treatment for mental disorder.
We are a National Specialist Service, which means that we are one of over 80 national services in Scotland, receiving funding directly from the National Services Division (NSD) of NHS Scotland. Referral, assessment, and treatment are cost-free to NHS Boards in Scotland.
We have considerable experience in the fields of neuromodulation, and expert-led psychopharmacology, along with being the only multi-disciplinary neurosurgical service in the UK for psychiatric disorders.
We offer specialist treatment for OCD and depression. We also provide expert diagnostic assessments for related conditions, and can offer advice on treatment. Select an option to read more...
We offer a range of interventions for OCD, including:
We have longstanding expertise in assessing and treating mood disorders, including depression. We can provide:
We are able to assess complex and treatment-refractory bipolar disorder(s) and offer advice on treatment.
For individuals with chronic and treatment-refractory bipolar depression, we can provide guidance on the suitability of neurosurgical treatments.
The coronavirus pandemic has affected all NHS services and we are committed to providing as full a service as possible to patients and referring clinicians. Our inpatient intensive treatment programme is now available.
A slightly more detailed description on how we have had to adapt services can be found on our COVID-19 page. Otherwise, please click on the relevant tab to find out more...
We continue to accept referrals. If you have any questions about a possible referral, or would like to discuss something, please get in touch.
We are adopting a 'digital by default' approach which means we will still aim to assess most people via videoconference (Zoom, Skype, etc.). This means that people can be assessed in the comfort of their own homes and do not have to travel. We are confident that this allows a comprehensive review of the patient's condition so that treatment recommendations can be made.
Where people are unable to be assessed remotely, or if we need to complete the assessment face-to-face, we will arrange this. We will still be following all relevant COVID-19 restrictions and all staff in the department have been vaccinated against COVID-19.
Over the last year we have provided online intensive treatment to those individuals who require more specialist interventions. This is likely to continue, but for those people who have not benefited from such treatment or need inpatient treatment, we are pleased to be able to offer inpatient treatment from May 2021.
It remains possible for people to travel to London for surgery. We are in close contact with neurosurgical colleagues in London who perform the surgery so that we can make sure that arrangements suit each person, whilst keeping risks as low as possible. At the current time, it is highly likely that people will be asked to self-isolate *before* travelling to London.
For people who would normally be reviewed in Dundee because they have previously had neurosurgical treatment or received intensive treatment, we will be getting in touch to discuss options for conducting the clinical part of the review via videoconference.
We are now able to arrange neuropsychological assessment and MRI scanning in Dundee but we will discuss this with the individual as some people might prefer not to travel just yet.
Please browse our resources for information on how to treat OCD and depression. We also publish our annual reports covering activity and outcomes.
If you would like further information on referral, or are a clinician who wishes to make a referral, please click on the button to view our referral FAQ.
We try to provide updated information on treatment, and comment on issues that relate to OCD and depression.
It is fairly well known that people with OCD have symptoms for a long time before seeking help, and wait longer before receiving effective treatment. In light of a new study from Brazil about the speed of development of OCD symptoms (Thompson et al,...Read More
In this blog, I review six randomised, controlled trials comparing N-Acetylcysteine (NAC) versus placebo for the treatment of OCD. NAC is a glutamate regulator and has good tolerability. Four trials tested it in adults, and two tested it in children.Read More
The pandemic has had a dramatic effect on the whole of the NHS, but it has also affected the availability of services for OCD. Not only that, but the nature of the pandemic will have had effects on many people with OCD; particularly those with...Read More